US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 4, 2017 (9 years ago)

Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.

What was recalled

Viokace (pancrelipase) tablets, 20,880 USP units, 100-count bottle, Rx only, Distributed by; Allergan USA Inc., Irvine, CA 92612, Manufactured in Canada, NDC 58914-117-10

Recalling firm
Allergan
NDC code
58914-117-10
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0154-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pancrelipase recalls

See all